Biotech · Private company
Radius Pharmaceuticals, Inc.
Track this companyFree. Adds Radius Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials70 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Cannabidiol Oral SolutionPhase 3 · Infantile SpasmClinicalTrials.gov · fetched Nov 12, 2026
- RAD011Phase 3 · Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- VigabatrinPhase 3 · Infantile SpasmClinicalTrials.gov · fetched Nov 12, 2026
- CannabidiolPhase 2 · Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Cannabidiol Oral SolutionPhase 2 · Childhood Absence EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- Cannabidiol Oral SolutionPhase 2 · Prader-Willi SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- RAD1901Phase 2 · Vasomotor SymptomsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi SyndromePHASE2_PHASE3 · TERMINATED · started Apr 13, 2022ClinicalTrials.gov NCT05098509 · fetched Nov 12, 2026
- A Study to Assess the Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Participants With Prader-Willi SyndromePHASE2 · TERMINATED · started Sep 6, 2018ClinicalTrials.gov NCT03458416 · fetched Nov 12, 2026
- A Study to Assess Cannabidiol Oral Solution With Vigabatrin as Initial Therapy in Participants With Infantile SpasmsPHASE3 · TERMINATED · started Sep 5, 2018ClinicalTrials.gov NCT03421496 · fetched Nov 12, 2026
- Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi SyndromePHASE2 · TERMINATED · started May 9, 2018ClinicalTrials.gov NCT02844933 · fetched Nov 12, 2026
- Long-Term Safety of Pharmaceutical Grade Synthetic Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresPHASE2 · TERMINATED · started Feb 20, 2018ClinicalTrials.gov NCT03355300 · fetched Nov 12, 2026
- Cannabidiol Oral Solution in Pediatric Participants With Treatment-Resistant Childhood Absence SeizuresPHASE2 · TERMINATED · started Dec 29, 2017ClinicalTrials.gov NCT03336242 · fetched Nov 12, 2026
- Study to Evaluate the Safety and Efficacy of RAD1901 in Postmenopausal Women With Moderate to Severe Vasomotor SymptomsPHASE2 · TERMINATED · started Dec 1, 2015ClinicalTrials.gov NCT02653417 · fetched Nov 12, 2026